MedTrace Logo

Comparison Between Breath Acetone and Blood Beta-Hydroxybutyrate

NCT03299543 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 61

Last updated 2018-08-29

No results posted yet for this study

Summary

Subjects will provide blood and breath samples to evaluate the relationship between breath acetone and two blood-bound species: beta-hydroxybutyrate and glucose. Subjects will be asked to provide breath and blood samples at a baseline visit and second optional visit. The two visits will be spaced approximately 3 hours apart.

Conditions

  • Ketosis

Interventions

DEVICE

LEVL (Medamonitor)

Subjects will provide duplicate breath samples to the LEVL device for analysis of breath acetone

Sponsors & Collaborators

  • Medamonitor

    lead INDUSTRY

Principal Investigators

  • Joseph C Anderson, PhD · Medamonitor

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-09-12
Primary Completion
2018-02-16
Completion
2018-02-28
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03299543 on ClinicalTrials.gov